Trial record 7 of 18 for:
"Conn's syndrome"
Adrenal Tumors - Pathogenesis and Therapy
This study is currently recruiting participants.
Verified July 2010 by University of Wuerzburg
Sponsor:
University of Wuerzburg
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Information provided by:
University of Wuerzburg
ClinicalTrials.gov Identifier:
NCT00669266
First received: April 28, 2008
Last updated: July 6, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
| Condition |
|---|
|
Adrenal Tumors Adrenocortical Carcinoma Cushing Syndrome Conn Syndrome Pheochromocytoma |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control |
| Official Title: | Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen |
Resource links provided by NLM:
Genetics Home Reference related topics:
Cushing disease
familial hyperaldosteronism
hereditary paraganglioma-pheochromocytoma
nonsyndromic paraganglioma
U.S. FDA Resources
Further study details as provided by University of Wuerzburg:
Biospecimen Retention: Samples With DNA
Germline DNA Tumor samples Serum Plasma Urine
| Estimated Enrollment: | 500 |
| Study Start Date: | September 2002 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| 1 |
| 2 |
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients with adrenal tumors
Criteria
Inclusion Criteria:
- adrenal tumor detected by imaging
Exclusion Criteria:
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00669266
Contacts
| Contact: Martin Fassnacht, MD | 49-931-201-36507 | fassnacht_m@medizin.uni-wuerzburg.de |
Locations
| Germany | |
| University of Wuerzburg | Recruiting |
| Wuerzburg, Germany, 97080 | |
| Contact: Martin Fassnacht, MD fassnacht_m@medizin.uni-wuerzburg.de | |
| Contact: Stefanie Hahner, MD hahner_s@medizin.uni-wuerzburg.de | |
| Principal Investigator: Martin Fassnacht, MD | |
Sponsors and Collaborators
University of Wuerzburg
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Investigators
| Principal Investigator: | Martin Fassnacht, MD | U of Wuerzburg |
More Information
No publications provided
| Responsible Party: | Martin Fassnacht, MD, University of Wuerzburg |
| ClinicalTrials.gov Identifier: | NCT00669266 History of Changes |
| Other Study ID Numbers: | Wue-Adrenal-Tumors-92/2002 |
| Study First Received: | April 28, 2008 |
| Last Updated: | July 6, 2010 |
| Health Authority: | Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Adrenal Gland Neoplasms Carcinoma Cushing Syndrome Pheochromocytoma Adrenocortical Carcinoma Hyperaldosteronism Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Adrenal Gland Diseases Endocrine System Diseases |
Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Adrenocortical Hyperfunction Paraganglioma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Adenocarcinoma Adrenal Cortex Neoplasms Adrenal Cortex Diseases |
ClinicalTrials.gov processed this record on May 21, 2013